France - English - HMA (Heads of Medicines Agencies)

cz veterinaria - mycobacterium bovis purified 25000 iu/ml - solution for injection - cattle - bovine tuberculin ppd

Hungary - English - HMA (Heads of Medicines Agencies)

cz veterinaria - mycobacterium bovis purified 25000 iu/ml - solution for injection - cattle - bovine tuberculin ppd

Ireland - English - HMA (Heads of Medicines Agencies)

cz veterinaria - mycobacterium bovis purified 25000 iu/ml - solution for injection - cattle - bovine tuberculin ppd

Portugal - English - HMA (Heads of Medicines Agencies)

cz veterinaria - mycobacterium bovis purified 25000 iu/ml - solution for injection - cattle - bovine tuberculin ppd

Singapore - English - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - live attenuated mycobacterium bovis (bcg) danish 1331 - injection, powder, for solution - 0.75 mg/ml - live attenuated mycobacterium bovis (bcg) danish 1331 0.75 mg/ml

United States - English - NLM (National Library of Medicine)

sanum kehlbeck gmbh & co. kg - mycobacterium phlei (unii: t67520t45f) (mycobacterium phlei - unii:t67520t45f) - homeopathic decongestant/bronchodilator medicine 0.17 fl oz (5 ml) for temporary relief of flu symptoms

United States - English - NLM (National Library of Medicine)

sanpharma gmbh - mycobacterium phlei (unii: t67520t45f) (mycobacterium phlei - unii:t67520t45f) - for immune support.

United States - English - NLM (National Library of Medicine)

sanpharma gmbh - mycobacterium phlei (unii: t67520t45f) (mycobacterium phlei - unii:t67520t45f) - for immune support.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - microbiology - it is for use with the bd probetec et system, utilizes strand displacement amplification (sda) technology for the identification of mycobacterium tuberculosis complex isolated from culture.

Singapore - English - HSA (Health Sciences Authority)

becton dickinson holdings pte. ltd. - microbiology - it is for use with the bd probetec et system, utilizes strand displacement amplification (sda) technology for the direct qualitative detection of mycobacterium buberculosis complex dna from decontaminated, digested clinical respiratory samples such as sputa, induced sputa, bronchial washings and other respiratory specimens. it is to be used as a direct test for evaluating specimens from untreated patients that are suspected of having tuberculosis. untreated patients are those who have: (1) not received anti-tuberculosis therapy; (2) not received such therapy in the last 12 months; or (3) had less than 7 days of therapy.